Aktuelle Meldungen

29.03.16
XENiOS® AG Enrolls First Patient in “SynCor” Clinical Trial of its CE-Marked i-cor® Device to Treat Cardiogenic Shock

Pressemitteilung der Xenios AG vom 29.03.2016